NfL level is a marker of neuro-axonal damage in diseases such as Alzheimer's disease, Parkinson's disease, multiple sclerosis, or amyotrophic lateral sclerosis, where high concentrations of NfL have been reported (Gaetani et al., 2019; Dhiman et al., 2020). The gene discussed is NEFL; the disease is Parkinson disease.